首页> 外文期刊>Pediatric Pulmonology >Progression of lung disease in primary ciliary dyskinesia: Is spirometry less accurate than CT?
【24h】

Progression of lung disease in primary ciliary dyskinesia: Is spirometry less accurate than CT?

机译:原发性睫状运动障碍的肺部疾病进展:肺活量测定法是否比CT准确度低?

获取原文
获取原文并翻译 | 示例
       

摘要

Despite its extensive use, there is no evidence that spirometry is useful in the assessment of progression of lung disease in primary ciliary dyskinesia (PCD). We hypothesize that high-resolution computed tomography (HRCT) is a better indicator of PCD lung disease progression than spirometry. We retrospectively evaluated two paired spirometry and HRCT examinations from 20 PCD patients (age, 11.6 years; range, 6.5-27.5 years). The evaluations were performed in stable state and during unstable lung disease. HRCT scans were scored blind by two raters. Compared to the first assessment, at the second evaluation spirometry did not change while HRCT scores significantly worsened (P 0.01). Age was significantly related to HRCT total (r = 0.5; P = 0.02) and bronchiectasis scores (r = 0.5; P = 0.02). At both evaluations, HRCT total score correlated with FEV 1 (r = -0.5, P = 0.01; r = -0.7, P = 0.001, respectively) and FVC Z scores (r = -0.6, P = 0.006; r = -0.7, P = 0.001, respectively), and bronchiectasis score was related to FEV 1 (r = -0.5, P = 0.03; r = -0.6; P = 0.002, respectively) and FVC Z scores (r = -0.6, P = 0.008; r = -0.7, P = 0.001, respectively). No relationship was found between the change in HRCT scores and the change in spirometry. In PCD, structural lung disease may worsen despite spirometry being stable.
机译:尽管广泛使用了肺活量测定法,但没有证据表明肺活量测定法可用于评估原发性睫状运动障碍(PCD)的肺部疾病进展。我们假设,与肺活量测定法相比,高分辨率计算机断层扫描(HRCT)是PCD肺部疾病进展的更好指标。我们回顾性评估了来自20位PCD患者(年龄11.6岁;范围6.5-27.5岁)的两次肺活量测定和HRCT检查。评估是在稳定状态和不稳定肺部疾病期间进行的。 HRCT扫描由两名评分者打分。与第一次评估相比,在第二次评估中,肺活量没有变化,而HRCT评分显着恶化(P <0.01)。年龄与HRCT总得分(r = 0.5; P = 0.02)和支气管扩张评分(r = 0.5; P = 0.02)显着相关。在这两个评估中,HRCT总分与FEV 1(r = -0.5,P = 0.01; r ​​= -0.7,P = 0.001)和FVC Z得分(r = -0.6,P = 0.006; r = -0.7)相关。 ,分别为P = 0.001)和支气管扩张评分与FEV 1(r = -0.5,P = 0.03; r = -0.6; P = 0.002)和FVC Z评分(r = -0.6,P = 0.008)相关; r = -0.7,P = 0.001)。 HRCT分数的变化与肺活量测定的变化之间没有关系。在PCD中,尽管肺活量测定稳定,但结构性肺部疾病可能会恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号